Biography of Sander van Deventer
Last update: February 10, 2024Career
Sander was Chief Scientific Officer at Porton Biologics, and Executive Vice President, Research and Product Development at UniQure. Sander van Deventer joined VectorY Therapeutics in 2021. Sander served as Co-Founder and Chief Technology Officer at VectorY Therapeutics.
Sander van Deventer is currently Co-Founder and Chief Executive Officer at VectorY Therapeutics - View - VectorY Therapeutics org chart
Create your alert
to follow the career of Sander van Deventer.
Education
In 2004, Sander van Deventer completed a PhD in Internal Medicine and Gastroenterology at University of Amsterdam.
They have also studied at University of Amsterdam :
Find more alumni from University of Amsterdam
More about Sander van Deventer
Selected links
Do you need to know more about Sander van Deventer? More results.
Participate
Social media
- Sander van Deventer on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Sander van Deventer
The colleagues of Sander van Deventer
Company Colleagues
- At VectorY Therapeutics, Sander van Deventer has 11 colleagues including Arno de Wilde (Director), Marco Boorsma (Director)…
Industry Colleagues
- In the Biotechnology industry, Sander van Deventer has 30,266 colleagues in 2,283 companies located in 40 countries. 14,433 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Sander van Deventer.
